|
[1]
|
Xu, X., Chen, P., Wang, J., et al. (2020) Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of Its Spike Protein for Risk of Human Transmission. Science China Life Sciences, 63, 457-460. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ciotti, M., Ciccozzi, M., Pieri, M., et al. (2022) The COVID-19 Pandemic: Viral Variants and Vaccine Efficacy. Critical Reviews in Clinical Laboratory Sciences, 59, 66-75. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
中国疾病预防控制中心. 新型冠状病毒感染[EB/OL]. https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/, 2024-03-25.
|
|
[4]
|
李娜, 汪哲, 包云丽, 唐海茹, 黄俊, 于晓辉, 张久聪. 新冠肺炎后遗症的临床特征及研究进展[J]. 海南医学院学报, 2022, 28(14): 1041-1049.
|
|
[5]
|
陈盼, 杨剑, 肖永红. 新型冠状病毒疫苗的研究进展[J]. 医药导报, 2024, 43(2): 240-248.
|
|
[6]
|
Salman, A.M., Ahmed, I., Mohd, M.H., et al. (2021) Scenario Analysis of COVID-19 Transmission Dynamics in Malaysia with the Possibility of Reinfection and Limited Medical Resources Scenarios. Computers in Biology and Medicine, 133, Article 104372. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wangping, J., Ke, H., Yang, S., et al. (2020) Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared with Hunan, China. Frontiers in Medicine, 7, 169-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kain, M.P., Childs, M.L., Becker, A.D., et al. (2021) Chopping the Tail: How Preventing Superspreading Can Help to Maintain COVID-19 Control. Epidemics, 34, Article 100430. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Torneri, A., Libin, P., Vanderlocht, J., et al. (2020) A Prospect on the Use of Antiviral Drugs to Control Local Outbreaks of COVID-19. BMC Medicine, 18, Article No. 191. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Li, T., Liu, Y., Li, M., et al. (2020) Mask or No Mask for COVID-19: A Public Health and Market Study. PLOS ONE, 15, e0237691. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Reiner, R.C., Barber, R.M., Collins, J.K., et al. (2021) Modeling COVID-19 Scenarios for the United States. Nature Medicine, 27, 94-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sonabend, R., Whittles, L.K., Imai, N., et al. (2021) Non-Pharmaceutical Interventions, Vaccination, and the SARS-CoV-2 Delta Variant in England: A Mathematical Modelling Study. The Lancet, 398, 1825-1835. [Google Scholar] [CrossRef]
|
|
[13]
|
Djaafara, B.A., Whittaker, C., Watson, O.J., et al. (2021) Using Syndromic Measures of Mortality to Capture the Dynamics of COVID-19 in Java, Indonesia, in the Context of Vaccination Rollout. BMC Medicine, 19, Article No. 146. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Davies, N.G., Abbott, S., Barnard, R.C., et al. (2021) Estimated Transmissibility and Impact of SARS-CoV-2 Lineage B.1.1.7 in England. Science, 372, eabg3055. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Buckner, J.H., Chowell, G. and Springborn, M.R. (2021) Dynamic Prioritization of COVID-19 Vaccines When Social Distancing Is Limited for Essential Workers. Proceedings of the National Academy of Sciences, 118, e2025786118. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Moore, S., Hill, E.M., Tildesley, M.J., et al. (2021) Vaccination and Non-Pharmaceutical Interventions for COVID-19: A Mathematical Modelling Study. The Lancet Infectious Diseases, 21, 793-802. [Google Scholar] [CrossRef]
|
|
[17]
|
马知恩, 周义仓, 李承治. 常微分方程定性与稳定性方法[M]. 第2版. 北京: 科学出版社, 2015.
|
|
[18]
|
Sheng, Y., Cui, J.-A. and Guo, S. (2023) The Modeling and Analysis of the COVID-19 Pandemic with Vaccination and Isolation: A Case Study of Italy. Mathematical Biosciences and Engineering, 20, 5966-5992. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Bai, Y.-Z., Wang, X.-J. and Guo, S.-B. (2021) Global Stability of a Mumps Transmission Model with Quarantine Measure. Acta Mathematicae Applicatae Sinica, English Series, 37, 665-672. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ao, D., Lan, T., He, X., Liu, J., Chen, L., Baptista-Hon, D.T., Zhang, K. and Wei, X. (2022) SARS-CoV-2 Omicron Variant: Immune Escape and Vaccine Development. MedComm, 3, e126. [Google Scholar] [CrossRef] [PubMed]
|